Highlights Vaxil Bio Ltd.

Equities

VXL

CA92243L1076

Market Closed - Toronto S.E. Other stock markets 11:05:56 2024-05-22 EDT			5-day change	1st Jan Change
0.01 ^CAD	-.--%		-.--%	-60.00%

05-30	Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-27	Green Data Center Real Estate Inc. entered into a letter of intent to acquire Vaxil Bio Ltd. in a reverse merger transaction.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
Green Data Center Real Estate Inc. entered into a letter of intent to acquire Vaxil Bio Ltd. in a reverse merger transaction.	05-26	CI
Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Copper Bullet Mines Inc. cancelled the acquisition of Vaxil Bio Ltd. in a reverse merger transaction.	03-03	CI
Vaxil Bio Entered Into Letter Of Intent With Copper Bullet Mines In Respect Of A Proposed Reverse Takeover	01-10	MT
Copper Bullet Mines Inc. entered into a non-binding letter of intent to acquire Vaxil Bio Ltd. for CAD 15.8 million in a reverse merger transaction.	01-09	CI
Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-12	CI
Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Vaxil Bio Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
Vaxil Bio Provides Update on Research Activities	22-03-07	MT
Vaxil Bio Provides Final Results on Research With Ben-Gurion University	22-01-04	MT
Vaxil Bio Ltd. Provides an Update on the Results of in Vivo Efficacy Study for Licensed P-Esbp-DOX	22-01-04	CI
Vaxil Bio Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-25	CI
Vaxil Bio Will Not Move Ahead with the Acquisition of Short Wave Pharma Following Due Diligence	21-11-11	MT
Vaxil Bio Ltd. cancelled the acquisition of Short Wave Pharma Inc.	21-11-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vaxil Bio Ltd.

Equities

VXL

CA92243L1076

Highlights

Filters